InsiderFlow

AARD

Aardvark Therapeutics, Inc. Common Stock$5.03-0.52 (-9.37%)
Prev Close$5.55·MCap$138.3M·P/E·Vol47.0K·Yield

Buys (12M)

2

$144.6K

Sells (12M)

1

$395.0K

Net Activity

Net Seller

$250.4K

Active Insiders

3

last 12 mo

Over the past 12 months, insider activity at Aardvark Therapeutics, Inc. Common Stock (AARD) has been dominated by selling, with 2 insider purchases totaling $144.6K and 1 insider sale totaling $395.0K. The most recent insider transaction was by Sun Nelson (officer: See Remarks), who sold $395.0K worth of shares on Sep 11, 2026. Aardvark Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $138.3M.

AARD Insider Trading Activity

DateInsiderTypeValue
Sep 11, 2026 Sun NelsonSell$395.0K
Dec 11, 2025 Lee Tien-LiBuy$101.4K
Dec 11, 2025 Sun NelsonBuy$43.2K
Sep 15, 2025 Lee Tien-LiBuy$96.6K
Sep 10, 2025 Lee Tien-LiBuy$160.7K
Sep 9, 2025 Sun NelsonBuy$48.4K
Feb 14, 2025 Lee Tien-LiBuy$264.7K
Feb 14, 2025 Sun NelsonBuy$160.0K

AARD Insider Buying Activity

The following table shows recent insider purchases of Aardvark Therapeutics, Inc. Common Stock (AARD) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Dec 11, 2025 Lee Tien-LiBuy$101.4K
Dec 11, 2025 Sun NelsonBuy$43.2K
Sep 15, 2025 Lee Tien-LiBuy$96.6K
Sep 10, 2025 Lee Tien-LiBuy$160.7K
Sep 9, 2025 Sun NelsonBuy$48.4K
Feb 14, 2025 Lee Tien-LiBuy$264.7K
Feb 14, 2025 Sun NelsonBuy$160.0K

AARD Insider Selling Activity

The following table shows recent insider sales of Aardvark Therapeutics, Inc. Common Stock (AARD) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Sep 11, 2026 Sun NelsonSell$395.0K

AARD Insiders

Sun Nelson

officer: See Remarks

Bought $251.6KSold $395.0K
4 tradesLast: Sep 11, 2026
Lee Tien-Li

Chief Executive Officer

Bought $623.3K
4 tradesLast: Dec 11, 2025